Assessment and management of behavioral disturbances in nursing home patients with dementia

Mayo Clinic Proceedings

Volumn 76, Issue 5, 2001, Pages 540-550

  Sutor, Bruce ^a   Rummans, Teresa A ^a   Smith, Glenn E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGITATION; ARTICLE; BEHAVIOR DISORDER; CAREGIVER; DEMENTIA; ENVIRONMENTAL FACTOR; HUMAN; MENTAL DISEASE; NURSING HOME;

EID: 0035025834     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.5.540     Document Type: Article

References (71)

1. German PS, Rovner BW, Burton LC, Brant LJ, Clark R. The role of mental morbidity in the nursing home experience. Gerontologist. 1992;32:152-158.
2. Rovner BW, German PS, Broadhead J, et al. The prevalence and management of dementia and other psychiatric disorders in nursing homes. Int Psychogeriatr. 1990;2:13-24.
3. Tariot PN, Mack JL, Patterson MB, et al, Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. The behavior rating scale for dementia of the consortium to establish a registry for Alzheimer's disease. Am J Psychiatry. 1995 ; 152:1349-1357.
4. Teri L, Larson EB, Reifler B V. Behavioral disturbance in dementia of the Alzheimer's type. J Am Geriatr Soc. 1988;36:l-6.
5. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry. 1990; 147:1049-1051.
6. Levy ML, Cummings JL, Fairbanks LA, Bravi D, Calvani M, Carta A. Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am J Psychiatry. 1996;153:1438-1443.
7. Swearer JM, Drachman DA, O'Donnell BF, Mitchell AL. Troublesome and disruptive behaviors in dementia: relationships to diagnosis and disease severity. J Am Geriatr Soc. 1988;36:784-790.
8. Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL. A comparison of psychiatric symptoms in vascular dementia and Alzheimer' s disease. Am J Psychiatry. 1993; 150:1806-1812.
9. Lopez OL, Gonzalez MP, Becker JT, Reynolds CF, Sudilovsky A, DeKosky ST. Symptoms of depression in Alzheimer's disease, frontal lobe-type dementia, and subcortical dementia. Ann N Y AcadSci. 1995;769:389-392.
10. NIH Consensus Development Panel on Depression in Late Life. Diagnosis and treatment of depression in late life. JAMA. 1992; 268:1018-1024.
11. Mendez MF, Martin RJ, Smyth KA, Whitehouse PJ. Psychiatric symptoms associated with Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1990;2:28-33.
12. Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry. 1989;146:577-587.
13. Deutsch LH, Bylsma FW, Rovner BW, Steele C, Folstein MF. Psychosis and physical aggression in probable Alzheimer's disease. Am J Psychiatry. 1991;148:1159-1163.
14. Aarsland D, Cummings JL, Yenner G, Miller B. Relationship of aggressive behavior to other neuropsychiatrie symptoms in patients with Alzheimer's disease. Am J Psychiatry. 1996; 153:243-247.
15. Robinson A, Spencer B, White L. Understanding Difficult Behaviors: Some Practical Suggestions for Coping With Alzheimer's Disease and Related Illnesses. Ypsilanti: Geriatric Education Center of Michigan. Michigan State University; 1988.
16. Folks DG, Fuller WC. Anxiety disorders and insomnia in geriatric patients. Psychiatr Clin North Am. 1997:20:137-164.
17. Marsh CM. Psychiatric presentations of medical illness. Psychiatr Clin North Am. 1997;20:181-204.
18. Reifler BV, Larson E. Excess disability in demented elderly outpatients: the rule of halves. J Am Geriatr Soc. 1988;36:82-83.
19. Rummans TA, Evans JM, Krahn LE, Fleming KC. Delirium in elderly patients: evaluation and management. Mayo Clin Proc. 1995:70:989-998.
20. Ferrell BA, Ferrell BR, Rivera L. Pain in cognitively impaired nursing home patients. / Pain Symptom Manage. 1995; 10:591 -598.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
22. Salmon DP. Neuropsychiatrie measures for cognitive disorders. In: American Psychiatric Association, Task Force for the Handbook of Psychiatric Measures. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000:417-455.
23. Cummings JL. The Neuropsychiatrie Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(5, suppl 6): S10-S16.
24. Yesavage JA. Geriatric Depression Scale. Ps\chopharmacol Bull. 1988;24:709-711.
25. Cohen-Mansfield J. Assessment of disruptive behavior/agitation in the elderly: function, methods, and difficulties. J Geriatr Psychiatry Neural. \995;8:52-60.
26. Lyketsos CG, Steinberg M. Behavioral measures for cognitive disorders. In: American Psychiatric Association, Task Force for the Handbook of Psychiatric Measures. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000: 393-416.
27. Yonkers KA, Samson J. Mood disorders measures. In: American Psychiatric Association, Task Force for the Handbook of Psychiatric Measures. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000:515-548.
28. Carlson DL, Fleming KC, Smith GE, Evans JM. Management of dementia-related behavioral disturbances: a nonpharmacologic approach. Mayo Clin Proc. 1995;70:1108-1115.
29. Hellen CR. Alzheimer's Disease: Activity-Focused Care. Boston, Mass: Andover Medical Publishers; 1992.
30. Whall AL, Black ME, Groh CJ, Yankou DJ, Kupferschmid BJ, Foster NL. The effect of natural environments upon agitation and aggression in late stage dementia patients. Am J Alzheimer Dis. 1997;12:216-220.
31. Dawson P, Kline K, Wiancko DC, Wells D. Preventing excess disability in patients with Alzheimer's disease. Geriatr Nurs. 1986; 7:298-301.
32. Boucher LA. Disruptive behaviors in individuals with Alzheimer's disease: a behavioral approach. Am J Alzheimer Dis. 1999;14:351356.
33. Synder LH, Rupprecht P, Pyrek J, Brekhus S, Moss T. Wandering. Gerontologist. 1978;18:272-280.
34. Folstein M, Anthony JC, Parhad I, Duffy B, Gruenberg EM. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc. 1985;33:228-235.
35. Loebel JP, Leibovici A. The management of other psychiatric states: hallucinations, delusions, and other disturbances. Med Clin North Am. 1994;78:841-859.
36. Cohen-Mansfield J, Billig N. Agitated behaviors in the elderly, I: a conceptual review. J Am Geriatr Soc. 1986;34:711-721.
37. Expert Consensus Panel for Agitation in Dementia. Treatment of agitation in older persons with dementia. Postgrad Med. April 1998;SpecNo.:l-88.
38. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc. 1990;38:553-563.
39. Devanand DP, Marder K, Michaels KS, et al. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry. 1998;155:1512-1520.
40. Woerner MG, Alvir JM, Kane JM, Saltz BL, Lieberman JA. Neuroleptic treatment of elderly patients. Psychopharmacol Bull. 1995;31:333-337.
41. Woerner MG, Alvir JM, Saltz BL, Lieberman JA, Kane JM. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry. 1998;155:1521-1528.
42. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M, Risperidone Study Group. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry. 1999;60: 107-115.
43. Workman RH, Orengo ÇA, Bakey AA, Molinari VA, Kunik ME. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1997;9:594-597.
44. Jeste DV, Okamoto A, Napolitano J, Kane JM, Martinez RA. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone. Am J Psychiatry. 2000; 157: 1150-1155.
45. Street JS, Clark WS, Cannon KS, et al, HGEU Study Group. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a doubleblind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2000;57:968-976.
46. Chambers CA, Bain J, Rossbottom R, et al. Carbamazepine in senile dementia and overactivity-a placebo controlled double blind trial. IRCS Med Sci. 1982; 10:505-506.
47. Tariot PN, Erb R, Podgorski ÇA, et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry. 1998;155:54-61.
48. Tariot PN, Frederiksen K, Erb R, et al. Lack of carbamazepine toxicity in frail nursing home patients: a controlled study. J Am GeriatrSoc. 1995;43:1026-1029.
49. Lott AD, McElroy SL, Keys MA. Valproate in the treatment of behavioral agitation in elderly patients with dementia. J Neuropsychiatry Clin Neurosci. 1995;7:314-319.
50. Sival RC, Haffmans PM, van Gent PP, van Nieuwkerk JF. The effects of sodium valproate on disturbed behavior in dementia [letterJ. J Am GeriatrSoc. 1994;42:906-907.
51. Narayan M, Nelson JC. Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic. J Clin Psychiatry. 1997;58:351-354.
52. Grossman F. A review of anticonvulsants in treating agitated demented elderly patients. Pharmacotherapy. 1998;18:600-606.
53. Goldenberg G, Kahaner K, Basavaraju N, Rangu S. Gabapentin for disruptive behaviour in an elderly demented patient [letterJ. Drugs Aging. 1998;13:183-184.
54. Devarajan S, Dursun SM. Aggression in dementia with lamotrigine treatment [letterJ. Am J Psychiatry. 2000; 157:1178.
55. Hawkins JW, Tinklenberg JR, Sheikh JI, Peyser CE, Yesavage JA. A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. Am J Geriatr Psychiatry. 2000;8:221-225.
56. Sanders JF. Evaluation of oxazepam and placebo in emotionally disturbed aged patients. Geriatrics. 1965;20:739-746.
57. Beber CR. Management of behavior in the institutionalized aged. Dis Nerv Syst. 1965;26:591-595.
58. De Lemos GP, Clement WR, Nickels E. Effects of diazepam suspension in geriatric patients hospitalized for psychiatric illnesses. J Am GeriatrSoc. 1965;13:355-359.
59. Shelton PS, Hocking LB. Zolpidem for dementia-related insomnia and nighttime wandering. Ann Pharmacother. 1997;31:319-322.
60. Herrmann N, Eryavec G. Buspirone in the management of agitation and aggression associated with dementia. Am J Geriatr Psychiatry. 1993; 1:249-253.
61. Sakauye KM, Camp CJ, Ford PA. Effects of buspirone on agitation associated with dementia. Am J Geriatr Psychiatry. 1993; 1:82-84.
62. Cantillon M, Brunswick R, Molina D, Bahro M. Buspirone vs. haloperidol: a double-blind trial for agitation in a nursing home population with Alzheimer's disease. Am J Geriatr Psychiatry. 1996;4:263-267.
63. Olafsson K, Jorgensen S, Jensen HV, Bille A, Arup P, Andersen J. Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study. Acta Psychiatr Scand. 1992;85:453-456.
64. Geldmacher DS, Waldman AJ, Doty L, Heilman KM. Fluoxetine in dementia of the Alzheimer's type: prominent adverse effects and failure to improve cognition [letterJ. / Clin Psychiatry. 1994;55:161.
65. Nyth AL, Gottfries CG, Lyby K, et al. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand. 1992;86:138-145.
66. Lebert F, Pasquier F, Petit H. Behavioral effects of trazodone in Alzheimer's disease. J Clin Psychiatry. 1994;55:536-538.
67. Greendyke RM, Kanter DR, Schuster DB, Verstreate S, Wootton J. Propranolol treatment of assaultive patients with organic brain disease: a double-blind crossover, placebo-controlled study. J Nerv Ment Dis. 1986;174:290-294.
68. Greendyke RM, Schuster DB, Wooton JA. Propranolol in the treatment of assaultive patients with organic brain disease. / Clin Psychopharmacol. 1984;4:282-285.
69. Kyomen HH, Nobel KW, Wei JY. The use of estrogen to decrease aggressive physical behavior in elderly men with dementia J Am GeriatrSoc. 1991 ;39:1110-1112.
70. Kaufer DI, Cummings JL, Christine D. Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neural. 1996;9:1-6.
71. Tomac TA, Rummans TA, Pileggi TS, Li H. Safety and efficacy of electroconvulsive therapy in patients over age 85. Am J Geriatr Psychiatry. 1997 ;5:126-130.